Pharmaceutical / Drug Definition :
Slows diastolic depolarization rate, reduces upstroke velocity, and prolongs duration of action potential and refractory period. Also decreases disparity in refractoriness between infarcted and adjacent normally perfused myocardium.
FDA Label Requirements and Exceptions
Disopyramide Phosphate
FDA Import Information
Disopyramide Phosphate
FDA Detentions
Disopyramide Phosphate (Disopyramide Phosphate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Disopyramide Phosphate (Disopyramide Phosphate Suppliers)
- Processors Disopyramide Phosphate
- Repackers Disopyramide Phosphate
- Relabelers Disopyramide Phosphate
- Exporters Disopyramide Phosphate
- Importers Disopyramide Phosphate
For more information about Disopyramide Phosphate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
